tiprankstipranks
Keymed Biosciences, Inc. (HK:2162)
:2162
Hong Kong Market

Keymed Biosciences, Inc. (2162) Cash flow

Compare
1 Followers

Keymed Biosciences, Inc. Cash Flow

HK:2162's free cash flow for Q2 2024 was ¥-473.35M. For the 2024 fiscal year, HK:2162's free cash flow was decreased by ¥-4.75M and operating cash flow was ¥-365.92M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
¥ -303.62M¥ -401.93M¥ -214.64M¥ -119.36M¥ -68.38M
Investing Cash Flow
¥ 468.20M¥ -645.59M¥ -2.04B¥ -113.07M¥ -58.02M
Financing Cash Flow
¥ 72.13M¥ -8.06M¥ 3.64B¥ 7.40M¥ 505.07M
End Cash Position
¥ 851.03M¥ 604.07M¥ 1.52B¥ 199.41M¥ 432.61M
Free Cash Flow
¥ -686.23M¥ -681.48M¥ -387.50M¥ -139.26M¥ -130.68M
Currency in CNY

Keymed Biosciences, Inc. Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis